Accepted for Publication: April 8, 2014.
Published Online: July 23, 2014. doi:10.1001/jamadermatol.2014.821.
Study concept and design: Pham-Ledard, Beylot-Barry, Merlio, Grange.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Pham-Ledard, Cappellen, Merlio, Grange.
Critical revision of the manuscript for important intellectual content: Pham-Ledard, Beylot-Barry, Barbe, Leduc, Petrella, Vergier, Martinez, Merlio, Grange.
Statistical analysis: Barbe, Leduc.
Obtained funding: Beylot-Barry.
Administrative, technical, or material support: Beylot-Barry, Martinez, Cappellen.
Study supervision: Beylot-Barry, Vergier, Merlio, Grange.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work is part of the REV-LEG Programme Hospitalier de la Recherche Clinique grant to Centre Hospitalier Universitaire Bordeaux number 2011-28, and received funding from Celgene. This study was designed based on a clinical study conducted on this series13 funded by the Société Française de Dermatologie. This work was conducted as part of the SIRIC BRIO program (Site de Recherche Intégrée sur le Cancer-Bordeaux Recherche Intégrée Oncologie), grant INCa-DGOS-Inserm 6046.
Role of the Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: The following physicians and pathologists of the French Study Group for Cutaneous Lymphomas provided data or samples: Pascal Joly, MD, PhD, and Philippe Courville, MD, PhD (Departments of Dermatology and Pathology, Hôpital Charles Nicolle, Centre Hospitalier Universitaire, Rouen, France); Martine Bagot, MD, PhD, and Caroline Ram-Wolff, MD, PhD (Departments of Dermatology and Pathology, Hôpital Saint-Louis, Paris, France); Stéphane Dalle, MD, PhD, and Brigitte Balme, MD, PhD (Departments of Dermatology and Pathology, Hôpital de l’Hôtel-Dieu, Lyon, France); Eve Maubec, MD, PhD (Department of Dermatology, Hôptial Bichat, Paris); Michel D’Incan, MD, PhD, and Pierre Dechelotte, MD, PhD (Departments of Dermatology and Pathology, Hotel-Dieu, Clermont-Ferrand, France); Sophie Dalac, MD, PhD (Department of Dermatology, Hôptital du Bocage, Dijon, France); Gaëlle Quéreux, MD, PhD (Department of Dermatology, Hôpital de l’Hôtel-Dieu, Nantes, France); and Olivier Dereure, MD, PhD, and Eric Frouin, MD, PhD (Department of Dermatology, Hôptial Aviecenne, Bobigny, France). Martina Carlotti, PhD (Equipe d’accueil 2406, Histology and Molecular Pathology of Tumors, Universitaire Bordeaux, Bordeaux, France), Nathalie Carrere, PhD (Tumor Bank and Tumor Biology Laboratory, Centre Hospitalier Universitaire Bordeaux), and Christine Alfaro, MS (Department of Dermatology, Centre Hospitalier Universitaire Bordeaux), provided advice and help with acquiring and analyzing the data. No financial compensation was given. Most samples were collected through the Tumor Bank of Centre Hospitalier Universitaire de Bordeaux.